Evaluation of nonenzymatic posttranslational modification-derived products as biomarkers of molecular aging of proteins

Clinical Chemistry

Volumn 56, Issue 9, 2010, Pages 1401-1412

  Jaisson, Stéphane ^a   Gillery, Philippe ^a  

^a AMERICAN MEMORIAL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

AGING; AMADORI REARRANGEMENT; ANALYTIC METHOD; ATHEROSCLEROSIS; BODY FLUID; CARBAMOYLATION; CHRONIC KIDNEY FAILURE; DEGENERATIVE DISEASE; DIABETES MELLITUS; DISEASE MARKER; GLYCATION; HUMAN; IN VIVO STUDY; MASS SPECTROMETRY; METABOLIC DISORDER; OSTEOPOROSIS; OXIDATION; PROTEIN PROCESSING; RETINOPATHY; REVIEW; SENSITIVITY AND SPECIFICITY;

AGING; BIOLOGICAL MARKERS; BODY FLUIDS; CHROMATOGRAPHY, LIQUID; CLINICAL CHEMISTRY TESTS; HUMANS; MASS SPECTROMETRY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 77956389018     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.145201     Document Type: Review

References (81)

1. Soskic V, Groebe K, Schrattenholz A. Nonenzymatic posttranslational protein modifications in ageing. Exp Gerontol 2008;43:247-57.
2. Baynes JW. The clinical chemome: a tool for the diagnosis and management of chronic disease. Clin Chem 2004;50:1116-7.
3. Meerwaldt R, Links T, Zeebregts C, Tio R, Hillebrands JL, Smit A. The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes. Cardiovasc Diabetol 2008;7:29.
4. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001;44:129-46.
5. Hamada Y, Araki N, Koh N, Nakamura J, Horiuchi S, Hotta N. Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway. Biochem Biophys Res Commun 1996;228:539-43. (Pubitemid 26396108)
6. Ahmed N, Thornalley PJ. Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes Metab 2007;9:233-45.
7. Witko-Sarsat V, Nguyen-Khoa T, Jungers P, Drueke TB, Descamps-Latscha B. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia. Nephrol Dial Transplant 1999;14 Suppl 1:76-8. (Pubitemid 29041848)
8. Ahmed N, Babaei-Jadidi R, Howell SK, Beisswenger PJ, Thornalley PJ. Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. Diabetologia 2005;48:1590-603. (Pubitemid 41175513)
9. Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem 2008;283:21837-41.
10. Lyons TJ. Glycation, carbonyl stress, EAGLEs, and the vascular complications of diabetes. Semin Vasc Med 2002;2:175-89.
11. Negre-Salvayre A, Coatrieux C, Ingueneau C, Salvayre R. Advanced lipid peroxidation end products in oxidative damage to proteins: potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol 2008;153:6-20.
12. Kraus LM, Kraus AP Jr. Carbamoylation of amino acids and proteins in uremia. Kidney Int Suppl 2001;78:S102-7.
13. Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Horkko S, Barnard J, et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 2007;13:1176-84. (Pubitemid 47530630)
14. McCudden CR, Kraus VB. Biochemistry of amino acid racemization and clinical application to musculoskeletal disease. Clin Biochem 2006;39:1112-30.
15. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis 2008;196:9-21.
16. Baynes JW. Chem modification of proteins by lipids in diabetes. Clin Chem Lab Med 2003;41:1159-65.
17. Grillo MA, Colombatto S. Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases. Amino Acids 2008;35:29-36.
18. Harding JJ. Viewing molecular mechanisms of ageing through a lens. Ageing Res Rev 2002;1:465-79.
19. Hein GE. Glycation endproducts in osteoporosis: is there a pathophysiologic importance? Clin Chim Acta 2006;371:32-6.
20. Lee JR, Kim JK, Lee SJ, Kim KP. Role of protein tyrosine nitration in neurodegenerative diseases and atherosclerosis. Arch Pharm Res 2009;32:1109-18.
21. Liu SX, Hou FF, Guo ZJ, Nagai R, Zhang WR, Liu ZQ, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 2006;26:1156-62. (Pubitemid 43732127)
22. Reddy VP, Zhu X, Perry G, Smith MA. Oxidative stress in diabetes and Alzheimer's disease. J Alzheimers Dis 2009;16:763-74.
23. Takeuchi M, Yamagishi S. Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease. J Alzheimers Dis 2009;16:845-58.
24. Thornalley PJ. Advanced glycation end products in renal failure. J Ren Nutr 2006;16:178-84.
25. Garnotel R, Sabbah N, Jaisson S, Gillery P. Enhanced activation of and increased production of matrix metalloproteinase-9 by human blood monocytes upon adhering to carbamylated collagen. FEBS Lett 2004;563:13-6. (Pubitemid 38471566)
26. Jaisson S, Lorimier S, Ricard-Blum S, Sockalingum GD, Delevallee-Forte C, Kegelaer G, et al. Impact of carbamylation on type I collagen conformational structure and its ability to activate human polymorphonuclear neutrophils. Chem Biol 2006;13:149-59. (Pubitemid 43255587)
27. Pedchenko VK, Chetyrkin SV, Chuang P, Ham AJ, Saleem MA, Mathieson PW, et al. Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy. Diabetes 2005;54:2952-60. (Pubitemid 41401092)
28. Gillery P, Monboisse JC, Maquart FX, Borel JP. Glycation of proteins as a source of superoxide. Diabete Metab 1988;14:25-30.
29. Shibayama R, Araki N, Nagai R, Horiuchi S. Autoantibody against N(epsilon)-(carboxymethyl)lysine: an advanced glycation end product of the Maillard reaction. Diabetes 1999;48:1842-9.
30. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006;114:597-605. (Pubitemid 44199649)
31. Buetler TM, Leclerc E, Baumeyer A, Latado H, Newell J, Adolfsson O, et al. N(epsilon)-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response. Mol Nutr Food Res 2008;52:370-8.
32. Valencia JV, Weldon SC, Quinn D, Kiers GH, DeGroot J, TeKoppele JM, Hughes TE. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics. Anal Biochem 2004;324:68-78. (Pubitemid 37491125)
33. Thornalley PJ. Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE): an introduction. Mol Nutr Food Res 2007;51:1107-10.
34. Wautier JL, Schmidt AM. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 2004;95:233-8.
35. Sobal G, Sinzinger H, Menzel EJ. Binding of long-term glycated low density lipoprotein and AGE-albumin by peripheral monocytes and endothelial cells. J Recept Signal Transduct Res 1999;19:267-81. (Pubitemid 29152187)
36. Ferretti G, Bacchetti T, Negre-Salvayre A, Salvayre R, Dousset N, Curatola G. Structural modifications of HDL and functional consequences. Atherosclerosis 2006;184:1-7. (Pubitemid 41721062)
37. Little RR. Glycated hemoglobin standardization: National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med 2003;41:1191-8.
38. Gillery P, Dumont G, Vassault A. Evaluation of GHb assays in France by national quality control surveys. Diabetes Care 1998;21:265-70. (Pubitemid 28079436)
39. Frantzen F. Chromatographic and electrophoretic methods for modified hemoglobins. J Chromatogr B Biomed Sci Appl 1997;699:269-86. (Pubitemid 27473715)
40. Fluckiger R, Woodtli T, Berger W. Quantitation of glycosylated hemoglobin by boronate affinity chromatography. Diabetes 1984;33:73-6. (Pubitemid 14187206)
41. Roberts NB, Green BN, Morris M. Potential of electrospray mass spectrometry for quantifying glycohemoglobin. Clin Chem 1997;43:771-8. (Pubitemid 27208780)
42. Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 2002;40:78-89.
43. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007;30:2399-400.
44. Johnson RN, Metcalf PA, Baker JR. Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 1983;127:87-95.
45. Wu YC, Monnier V, Friedlander M. Reliable determination of furosine in human serum and dialysate proteins by high-performance liquid chromatography. J Chromatogr B Biomed Appl 1995;667:328-32.
46. Sampathkumar R, Balasubramanyam M, Rema M, Premanand C, Mohan V. A novel advanced glycation index and its association with diabetes and microangiopathy. Metabolism 2005;54:1002-7.
47. Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans RO, et al. Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia 2009;52:789-97.
48. Scheijen JL, van de Waarenburg MP, Stehouwer CD, Schalkwijk CG. Measurement of pentosidine in human plasma protein by a single-column high-performance liquid chromatography method with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:610-4.
49. Ahmed N, Thornalley PJ. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence. Biochem J 2002;364:15-24.
50. Zhang X, Frischmann M, Kientsch-Engel R, Steinmann K, Stopper H, Niwa T, Pischetsrieder M. Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients. Clin Chem Lab Med 2005;43:503-11.
51. Petrovic R, Futas J, Chandoga J, Jakus V. Rapid and simple method for determination of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl) lysine in urine using gas chromatography/mass spectrometry. Biomed Chromatogr 2005;19:649-54.
52. Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, Dawnay A. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 2003;375:581-92.
53. Sell DR, Biemel KM, Reihl O, Lederer MO, Strauch CM, Monnier VM. Glucosepane is a major protein cross-link of the senescent human extracellular matrix: relationship with diabetes. J Biol Chem 2005;280:12310-5.
54. Requena JR, Fu MX, Ahmed MU, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem J 1997;322:317-25.
55. Selmeci L, Seres L, Antal M, Lukacs J, Regoly-Merei A, Acsady G. Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: a simple, fast and inexpensive automated technique. Clin Chem Lab Med 2005;43:294-7.
56. Heinecke JW, Hsu FF, Crowley JR, Hazen SL, Leeuwenburgh C, Mueller DM, et al. Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: sensitive and quantitative assays for oxidized amino acids in proteins and tissues. Methods Enzymol 1999;300:124-44.
57. Mashima R, Nakanishi-Ueda T, Yamamoto Y. Simultaneous determination of methionine sulfoxide and methionine in blood plasma using gas chromatography-mass spectrometry. Anal Biochem 2003;313:28-33.
58. Kato Y, Dozaki N, Nakamura T, Kitamoto N, Yoshida A, Naito M, et al. Quantification of modified tyrosines in healthy and diabetic human urine using liquid chromatography/tandem mass spectrometry. J Clin Biochem Nutr 2009;44:67-78.
59. Kwan JT, Carr EC, Bending MR, Barron JL. Determination of carbamylated hemoglobin by highperformance liquid chromatography. Clin Chem 1990;36:607-10.
60. Hasuike Y, Nakanishi T, Maeda K, Tanaka T, Inoue T, Takamitsu Y. Carbamylated hemoglobin as a therapeutic marker in hemodialysis. Nephron 2002;91:228-34.
61. Szymezak J, Lavalard E, Martin M, Leroy N, Gillery P. Carbamylated hemoglobin remains a critical issue in HbA1c measurements. Clin Chem Lab Med 2009;47:612-3.
62. Balion CM, Draisey TF, Thibert RJ. Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients. Kidney Int 1998;53:488-95.
63. Seljeskog E, Hervig T, Mansoor MA. A novel HPLC method for the measurement of thiobarbituric acid reactive substances (TBARS): a comparison with a commercially available kit. Clin Biochem 2006;39:947-54. (Pubitemid 44344684)
64. Lapolla A, Flamini R, Dalla Vedova A, Senesi A, Reitano R, Fedele D, et al. Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method. Clin Chem Lab Med 2003;41:1166-73. (Pubitemid 37265695)
65. Shibamoto T. Analytical methods for trace levels of reactive carbonyl compounds formed in lipid peroxidation systems. J Pharm Biomed Anal 2006;41:12-25.
66. Lal S, Kappler F, Walker M, Orchard TJ, Beisswenger PJ, Szwergold BS, Brown TR. Quantitation of 3-deoxyglucosone levels in human plasma. Arch Biochem Biophys 1997;342:254-60. (Pubitemid 27251246)
67. Uchida Y, Kurano Y, Endo T, Aoyama M, Ito S. Immunochemical detection of 3-deoxyglucosone in serum. Biochem Biophys Res Commun 2004;325:1090-8.
68. Guilloton M, Karst F. A spectrophotometric determination of cyanate using reaction with 2-aminobenzoic acid. Anal Biochem 1985;149:291-5. (Pubitemid 16238606)
69. 3H)-quinazolinedione and separation by highperformance liquid chromatography. Anal Biochem 1993;211:23-7.
70. Cohen MP, Hud E. Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELISA. J Immunol Methods 1989;122:279-83. (Pubitemid 19219437)
71. Klaya F, Durlach V, Bertin E, Monier F, Monboisse JC, Gillery P. Evaluation of serum glycated lipoprotein(a) levels in noninsulin-dependent diabetic patients. Clin Biochem 1997;30:227-30. (Pubitemid 27225356)
72. Shishino K, Murase M, Makino H, Saheki S. Glycated apolipoprotein A-I assay by combination of affinity chromatography and latex immunoagglutination. Ann Clin Biochem 2000;37(Pt 4):498-506. (Pubitemid 30426732)
73. Apostolov EO, Shah SV, Ok E, Basnakian AG. Quantification of carbamylated LDL in human sera by a new sandwich ELISA. Clin Chem 2005;51:719-28. (Pubitemid 40463923)
74. Pfutzner A, Efstrathios K, Lobig M, Armbruster FP, Hanefeld M, Forst T. Differences in the results and interpretation of oxidized LDL cholesterol by two ELISA assays: an evaluation with samples from the PIOstat study. Clin Lab 2009;55:275-81.
75. Ahmed N, Babaei-Jadidi R, Howell SK, Thornalley PJ, Beisswenger PJ. Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes. Diabetes Care 2005;28:2465-71.
76. Delpierre G, Rider MH, Collard F, Stroobant V, Vanstapel F, Santos H, Van Schaftingen E. Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. Diabetes 2000;49:1627-34.
77. Kalousova M, Zima T, Tesar V, Dusilova-Sulkova S, Skrha J. Advanced glycoxidation end products in chronic diseases: clinical chemistry and genetic background. Mutat Res 2005;579:37-46. (Pubitemid 41540131)
78. Priego Capote F, Sanchez JC. Strategies for proteomic analysis of non-enzymatically glycated proteins. Mass Spectrom Rev 2009;28:135-46.
79. Petibois C, Cazorla G, Cassaigne A, Deleris G. Plasma protein contents determined by Fourier-transform infrared spectrometry. Clin Chem 2001;47:730-8. (Pubitemid 32275818)
80. Glenn JV, Beattie JR, Barrett L, Frizzell N, Thorpe SR, Boulton ME, et al. Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging. FASEB J 2007;21:3542-52.
81. Ceriello A, Ihnat MA, Thorpe JE. Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab 2009;94:410-5.